Lab Med Qual Assur 2023; 45(3): 120-124
Published online September 30, 2023
https://doi.org/10.15263/jlmqa.2023.45.3.120
Copyright © Korean Association of External Quality Assessment Service.
Heejin So1 , Kyungsuk Kwon2 , Jungkyu Park2 , and Kyeongmi Kim2
1Department of Laboratory Medicine, Gimpo Woori Hospital, Gimpo; 2Department of Laboratory Medicine, CHA Ilsan Medical Center, CHA University School of Medicine, Goyang, Korea
Correspondence to:Kyeongmi Kim
Department of Laboratory Medicine, CHA Ilsan Medical Center, CHA University School of Medicine, 1205 Jungang-ro, Ilsandong-gu, Goyang 10414, Korea
Tel +82-31-782-8661
E-mail kmi0905@chamc.co.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Point-of-care (POC) tests for human chorionic gonadotropin (hCG) are widely used in hospital laboratories. However, there is a lack of comparative studies focusing on pregnancy POC devices that test urine. In this study, we aimed to evaluate four commonly used pregnancy POC devices in Korea. From March to May 2023, remnant clinical urine samples were collected from 200 patients, consisting of 100 confirmed pregnant women and 100 nonpregnant women. The evaluated devices included the AllCheck hCG Card (Calth, Korea), Card ASAN Easy Test hCG (Asanpharm., Korea), Humasis hCG Card (Humasis, Korea), and careUS BEBE-CHECK (Wells bio, Korea). Among the four pregnancy POC devices, we observed a 99% negative percent agreement and 97% positive percent agreement. Only four samples showed discrepancies in results, which could be attributed to early pregnancy and abortion. Overall, the hCG POC devices assessed in this study demonstrated high concordance rates. However, we must be careful when interpreting urine pregnancy test results, particularly in cases involving early pregnancy or abortion.
Keywords: Human chorionic gonadotropin, Pregnancy tests, Point-of-care systems
View Full Text | PubReader |
Abstract | Print this Article |
E-mail alert | Export to Citation |
Article as PDF | Open Access |